BioHarvest Sciences (BHST) Competitors $6.10 -0.14 (-2.24%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BHST vs. SAGE, AMLX, SANA, SIGA, PRTC, PRTA, KMDA, ERAS, PGEN, and TRMLShould you be buying BioHarvest Sciences stock or one of its competitors? The main competitors of BioHarvest Sciences include Sage Therapeutics (SAGE), Amylyx Pharmaceuticals (AMLX), Sana Biotechnology (SANA), SIGA Technologies (SIGA), PureTech Health (PRTC), Prothena (PRTA), Kamada (KMDA), Erasca (ERAS), Precigen (PGEN), and Tourmaline Bio (TRML). These companies are all part of the "pharmaceutical products" industry. BioHarvest Sciences vs. Sage Therapeutics Amylyx Pharmaceuticals Sana Biotechnology SIGA Technologies PureTech Health Prothena Kamada Erasca Precigen Tourmaline Bio BioHarvest Sciences (NASDAQ:BHST) and Sage Therapeutics (NASDAQ:SAGE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment. Do insiders and institutionals hold more shares of BHST or SAGE? 99.2% of Sage Therapeutics shares are held by institutional investors. 5.5% of Sage Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is BHST or SAGE more profitable? BioHarvest Sciences has a net margin of -76.65% compared to Sage Therapeutics' net margin of -971.50%. BioHarvest Sciences' return on equity of 0.00% beat Sage Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-76.65% N/A -85.16% Sage Therapeutics -971.50%-68.18%-60.84% Do analysts prefer BHST or SAGE? BioHarvest Sciences currently has a consensus target price of $13.67, indicating a potential upside of 124.04%. Sage Therapeutics has a consensus target price of $8.81, indicating a potential upside of 29.60%. Given BioHarvest Sciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe BioHarvest Sciences is more favorable than Sage Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Sage Therapeutics 2 Sell rating(s) 15 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility & risk, BHST or SAGE? BioHarvest Sciences has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, Sage Therapeutics has a beta of 0.2, suggesting that its share price is 80% less volatile than the S&P 500. Does the MarketBeat Community favor BHST or SAGE? Sage Therapeutics received 629 more outperform votes than BioHarvest Sciences when rated by MarketBeat users. However, 100.00% of users gave BioHarvest Sciences an outperform vote while only 64.92% of users gave Sage Therapeutics an outperform vote. CompanyUnderperformOutperformBioHarvest SciencesOutperform Votes4100.00% Underperform VotesNo VotesSage TherapeuticsOutperform Votes63364.92% Underperform Votes34235.08% Which has preferable valuation and earnings, BHST or SAGE? BioHarvest Sciences has higher earnings, but lower revenue than Sage Therapeutics. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Sage Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$27.70M3.62-$12.56M-$0.50-12.20Sage Therapeutics$47.40M8.98-$400.67M-$5.80-1.17 Does the media favor BHST or SAGE? In the previous week, Sage Therapeutics had 1 more articles in the media than BioHarvest Sciences. MarketBeat recorded 10 mentions for Sage Therapeutics and 9 mentions for BioHarvest Sciences. Sage Therapeutics' average media sentiment score of 0.88 beat BioHarvest Sciences' score of 0.56 indicating that Sage Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioHarvest Sciences 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sage Therapeutics 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryBioHarvest Sciences and Sage Therapeutics tied by winning 9 of the 18 factors compared between the two stocks. Get BioHarvest Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for BHST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHST vs. The Competition Export to ExcelMetricBioHarvest SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$100.19M$6.48B$5.35B$8.38BDividend YieldN/A2.66%5.22%4.10%P/E Ratio-4.888.9226.8419.71Price / Sales3.62250.96391.39116.98Price / CashN/A65.8538.2534.62Price / Book-5.656.466.794.50Net Income-$12.56M$143.98M$3.23B$248.18M7 Day Performance-7.58%3.04%4.07%1.14%1 Month Performance4.99%7.44%12.52%15.18%1 Year PerformanceN/A-2.46%16.83%6.55% BioHarvest Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHSTBioHarvest SciencesN/A$6.10-2.2%$13.67+124.0%N/A$100.19M$27.70M-4.88N/ANews CoverageEarnings ReportAnalyst RevisionGap UpSAGESage Therapeutics3.955 of 5 stars$6.56-2.2%$8.81+34.3%-36.2%$410.79M$47.40M-1.00690Analyst DowngradeAMLXAmylyx Pharmaceuticals3.4725 of 5 stars$4.61+0.7%$9.67+109.7%+200.0%$410.68M$87.37M-1.21200SANASana Biotechnology2.4474 of 5 stars$1.81flat$10.80+496.7%-75.8%$408.11MN/A-1.29380SIGASIGA Technologies1.3585 of 5 stars$5.66+4.0%N/A-17.9%$404.36M$138.72M4.7240PRTCPureTech Health1.5357 of 5 stars$16.78-2.7%$45.00+168.2%-39.3%$403.04M$4.32M0.00100Gap UpPRTAProthena3.7572 of 5 stars$7.43+4.6%$51.71+596.0%-67.8%$399.94M$135.16M-3.23130Positive NewsHigh Trading VolumeKMDAKamada3.9437 of 5 stars$6.88-1.6%$14.67+113.2%+26.8%$395.46M$160.95M24.57360Earnings ReportAnalyst RevisionERASErasca3.6125 of 5 stars$1.39flat$4.83+247.7%-42.9%$393.77MN/A-1.67120Gap UpPGENPrecigen3.4625 of 5 stars$1.33-1.5%$7.00+426.3%+1.4%$392.57M$3.93M-2.42190News CoverageEarnings ReportAnalyst RevisionGap DownTRMLTourmaline Bio2.0714 of 5 stars$15.09-4.1%$49.33+226.9%+11.3%$387.59MN/A-5.3544News Coverage Related Companies and Tools Related Companies Sage Therapeutics Competitors Amylyx Pharmaceuticals Competitors Sana Biotechnology Competitors SIGA Technologies Competitors PureTech Health Competitors Prothena Competitors Kamada Competitors Erasca Competitors Precigen Competitors Tourmaline Bio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BHST) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BHST Stock Free BHST Stock Alerts